Home  » Topic

Dr Reddys News


Dr Reddy's Labs Hits Record High On Settlement Of Patent Litigation
Shares of Dr Reddy's Laboratories soared 10 percent to hit a record high of Rs 5,302.85 after the pharma company informed the settlement of their litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, relating to patents for REVLIM (lenalidomide) ...
Dr Reddy's Labs Shares Hit All-Time High After Q1 Results
On Thursday, shares of Dr Reddy's Laboratories rose nearly 6 percent to a new all-time high of Rs 4,544 after the company reported a higher than expected profit for the June-ended quarter. The multinational pharma company posted a 12.6 percent ...
Dr Reddy S Labs Hits 52 Week High After Q1 Results
Dr Reddy's Shares Fall 10% As Profits Crash
Shares in Dr Reddy's came crashing down by a huge 10 per cent, after numbers at the company were a major disappointment. Dr Reddy's Labs reported a 75.6 per cent drop in June quarter consolidated net profit at Rs 153 ...
Sensex Ends Lower As Global Markets See Profit Booking
Benchmark indices ended the day lower, as global markets saw profit booking after a near 6-day rally across markets. The Sensex ended the day lower with losses of 111 points, while the Nifty closed lower by 40.50 points. Leading the ...
Sensex Ends Lower As Global Markets See Profit Booking
Dr. Reddy’s Shares Gain On Acquiring Products From Teva
Shares in Dr Reddy's gained ground after the company said that it had acquired the products portfolio from Teva. The stock was up 1 per cent in trade in a falling market, where the Sensex had lost almost 325 points. {image-buy-13-1465798421.jpg ...
Dr Reddy S Shares Gain On Acquiring Products From Teva
Pharma Stocks Continue To Fall After Tuesday's Slide
Pharma stocks continued to fall even after witnessing a sharp slide on Tuesday. Lupin, which lost 7 per cent on Tuesday was down another half per cent. There were worries over US FDA concerns over one of the plants of the ...
Dr Reddy's Continues To Fall; Nomura Cuts Target Price
Shares in Dr Reddy's continued to decline in trade, as Nomura cut the target to Rs 4,346 from 4,919 rupees. The shares of the company have fallen in the last few trading sessions after a US FDA warning and reports ...
Dr Reddy S Continues Fall Nomura Cuts Target Price
Why Indian Pharma Shares Have Become Risky Bets?
From being the safest bets until the last few months, pharma shares in the last few weeks have become the riskiest bets in the markets. The one and the only one reason is warning letters from the US FDA. Take the ...
Dr Reddy's Shares Crash On Fresh US FDA Worries
Shares in Dr Reddy's crashed after the US FDA identified significant deviations at the plants of the company it had inspected. Earlier this month the company was issued a warning letter from the US FDA for these three plants. The stock ...
Dr Reddy S Share Crash On Fresh Us Fda Worries
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X